Aleafia Health Inc.
ALEAF · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -12.9% | 2% | -12.1% | – |
| Cost of Goods Sold | $0 | $0 | -$0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | -21.1% | -122.8% | 147.8% | 47.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | -$0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -78.4% | -174.6% | 85.4% | -3.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | $0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -153.6% | -270.6% | 28.4% | -47.9% |
| EPS | -0.037 | -0.072 | 0.008 | -0.017 |
| % Growth | 48.5% | -1,065.3% | 144.9% | – |
| EPS Diluted | -0.037 | -0.072 | 0.008 | -0.017 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -68.9% | -160.7% | 105% | 14% |